See more : Imperial Metals Corporation (III.TO) Income Statement Analysis – Financial Results
Complete financial analysis of Beijing Scitop Bio-tech Co., Ltd. (300858.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Beijing Scitop Bio-tech Co., Ltd., a leading company in the Biotechnology industry within the Healthcare sector.
- Aurora Labs Limited (A3D.AX) Income Statement Analysis – Financial Results
- Banco de Valores S.A. (VALO.BA) Income Statement Analysis – Financial Results
- Diablo Resources Limited (DBO.AX) Income Statement Analysis – Financial Results
- PT Perintis Triniti Properti Tbk (TRIN.JK) Income Statement Analysis – Financial Results
- Univacco Technology Inc. (3303.TWO) Income Statement Analysis – Financial Results
Beijing Scitop Bio-tech Co., Ltd. (300858.SZ)
About Beijing Scitop Bio-tech Co., Ltd.
Beijing Scitop Bio-tech Co., Ltd. develops, produces, and sells probiotic lactic acid bacteria and related products in China. It also provides compound food additives, edible probiotic products, and animal and plant microecological preparations. Its products have applications in the food industry, health care, animal husbandry, and agricultural planting. Beijing Scitop Bio-tech Co., Ltd. was founded in 2003 and is headquartered in Beijing, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 299.24M | 369.17M | 364.62M | 339.16M | 308.10M | 317.90M | 283.76M | 260.62M | 185.41M |
| Cost of Revenue | 135.91M | 177.29M | 181.17M | 175.27M | 150.63M | 160.72M | 150.55M | 144.51M | 111.06M |
| Gross Profit | 163.33M | 191.88M | 183.45M | 163.88M | 157.46M | 157.17M | 133.20M | 116.11M | 74.35M |
| Gross Profit Ratio | 54.58% | 51.98% | 50.31% | 48.32% | 51.11% | 49.44% | 46.94% | 44.55% | 40.10% |
| Research & Development | 34.19M | 22.09M | 27.15M | 17.57M | 14.75M | 15.84M | 12.59M | 9.39M | 6.04M |
| General & Administrative | 2.51M | 7.63M | 15.78M | 6.34M | 4.65M | 7.26M | 5.99M | 65.88M | 13.18M |
| Selling & Marketing | 22.83M | 27.23M | 25.01M | 18.07M | 16.44M | 13.34M | 12.16M | 16.48M | 5.43M |
| SG&A | 25.35M | 34.86M | 40.79M | 24.41M | 21.09M | 20.61M | 18.16M | 82.35M | 18.61M |
| Other Expenses | 0.00 | -1.92M | -530.57K | -4.54M | -131.70K | -159.33K | -333.51K | 4.65M | 741.69K |
| Operating Expenses | 60.73M | 76.09M | 89.03M | 53.47M | 48.80M | 49.83M | 43.32M | 93.56M | 25.70M |
| Cost & Expenses | 196.64M | 253.38M | 270.19M | 228.74M | 199.43M | 210.55M | 193.87M | 238.07M | 136.76M |
| Interest Income | 24.00M | 3.64M | 6.74M | 3.50M | 156.89K | 311.63K | 149.77K | 3.30M | 1.28M |
| Interest Expense | 548.24K | 405.32K | 439.08K | 37.47K | 337.47K | 0.00 | 254.89K | 0.00 | 0.00 |
| Depreciation & Amortization | 20.34M | 18.22M | 16.52M | 10.58M | 5.83M | 2.22M | 2.19M | 1.28M | 2.93M |
| EBITDA | 123.92M | 144.75M | 128.34M | 124.27M | 116.80M | 109.12M | 91.84M | 24.75M | 49.45M |
| EBITDA Ratio | 41.41% | 39.19% | 35.20% | 36.14% | 37.37% | 35.25% | 32.73% | 8.30% | 26.67% |
| Operating Income | 102.60M | 127.58M | 124.70M | 117.71M | 110.72M | 107.06M | 87.84M | 20.12M | 46.52M |
| Operating Income Ratio | 34.29% | 34.56% | 34.20% | 34.71% | 35.94% | 33.68% | 30.95% | 7.72% | 25.09% |
| Total Other Income/Expenses | -560.66K | -1.92M | -530.57K | -4.54M | -131.70K | -159.33K | -333.51K | 4.65M | -594.63K |
| Income Before Tax | 102.04M | 125.66M | 124.17M | 113.18M | 110.58M | 106.90M | 87.50M | 24.77M | 47.27M |
| Income Before Tax Ratio | 34.10% | 34.04% | 34.06% | 33.37% | 35.89% | 33.63% | 30.84% | 9.50% | 25.49% |
| Income Tax Expense | 8.56M | 15.76M | 14.63M | 16.60M | 17.30M | 14.99M | 16.33M | 13.28M | 12.25M |
| Net Income | 93.48M | 109.89M | 109.54M | 96.58M | 93.28M | 91.92M | 71.35M | 11.54M | 35.02M |
| Net Income Ratio | 31.24% | 29.77% | 30.04% | 28.48% | 30.28% | 28.91% | 25.14% | 4.43% | 18.89% |
| EPS | 0.35 | 0.49 | 0.49 | 0.43 | 0.42 | 0.55 | 0.44 | 0.10 | 0.40 |
| EPS Diluted | 0.35 | 0.49 | 0.49 | 0.43 | 0.42 | 0.55 | 0.44 | 0.10 | 0.40 |
| Weighted Avg Shares Out | 267.09M | 223.39M | 222.80M | 222.80M | 222.80M | 166.57M | 163.25M | 119.79M | 88.36M |
| Weighted Avg Shares Out (Dil) | 267.09M | 223.39M | 222.80M | 222.80M | 222.80M | 166.57M | 163.25M | 119.79M | 88.36M |
Source: https://incomestatements.info
Category: Stock Reports